Possible involvement of the central dopaminergic system in the antireserpine effect of LSD.
D000818:Animals; D001058:Apomorphine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D002395:Catecholamines / Q000032:analysis; D003000:Clonidine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D008238:Lysergic Acid Diethylamide / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D008297:Male; D008635:Mescaline / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D010643:Phenoxybenzamine / Q000494:pharmacology; D011562:Psilocybin / Q000494:pharmacology; D011954:Receptors, Dopamine / Q000187:drug effects*; D012110:Reserpine / Q000037:antagonists & inhibitors
D002395:Catecholamines; D008781:Methyltyrosines; D011954:Receptors, Dopamine; D010643:Phenoxybenzamine; D011562:Psilocybin; D012110:Reserpine; D008238:Lysergic Acid Diethylamide; D003000:Clonidine; D001058:Apomorphine; D008635:Mescaline